MedPath
TGA Approval

JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle (291356)

291356

JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle

ViiV Healthcare Pty Ltd

June 20, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d41679c5e83359825864553f412f5a10.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b41d1bf46ffbab19ca0a1cc5753bdb69.pdf

Active Ingredients

dolutegravir

rilpivirine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle (291356) - TGA 批准文号 | MedPath